Hamostaseologie 2019; 39(01): 076-086
DOI: 10.1055/s-0038-1654720
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Lemierre Syndrome: Clinical Update and Protocol for a Systematic Review and Individual Patient Data Meta-analysis

Clara Sacco
1   Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy
,
Federica Zane
1   Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy
,
Serena Granziera
2   Department of Medicine (DIMED), Geriatric Clinic, University of Padua, Padua, Italy
3   Department of Physical and Rehabilitation Medicine, “Villa Salus” Hospital, Mestre, Italy
,
Karin Holm
4   Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden
,
Dina Creemers-Schild
5   Department of Internal Medicine, Langeland Hospital, Zoetermeer, The Netherlands
,
Michel-André Hotz
6   Department of ENT, Head and Neck Surgery, Inselspital (University Hospital of Bern), University of Bern, Bern, Switzerland
,
Elena Turpini
7   Department of Radiology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy
,
Adele Valentini
7   Department of Radiology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy
,
Christian Righini
8   Department of Otolaryngology–Head and Neck Surgery, Grenoble University Hospital, Grenoble, France
,
Petros D. Karkos
9   Department of Otolaryngology–Head and Neck Surgery, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Peter Verhamme
10   Department of Vascular Medicine and Haemostasis, University Hospitals Leuven, Leuven, Belgium
,
Marcello Di Nisio
11   Department of Medicine and Ageing Sciences, University G. D'Annunzio of Chieti-Pescara, Chieti, Italy
,
Stavros Konstantinides
12   Center for Thrombosis and Haemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
13   Department of Cardiology, Democritus University of Thrace, Alexandroupolis, Greece
,
Alessandro Pecci
1   Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy
,
Stefano Barco
12   Center for Thrombosis and Haemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
,
on behalf of the Lemierre Study Group › Author Affiliations
Further Information

Publication History

14 August 2017

09 March 2018

Publication Date:
02 August 2018 (online)

Abstract

Lemierre syndrome usually affects otherwise healthy adolescents or young adults and occurs at an overall rate of 1 to 10 cases per million person-years with an estimated fatality rate of 4 to 9%. Diagnostic criteria remain debated and include acute neck/head bacterial infection (often tonsillitis caused by anaerobes at high potential for sepsis and vascular invasion, notably Fusobacterium necrophorum) complicated by local vein thrombosis, usually involving the internal jugular vein, and systemic septic embolism. Medical treatment is based on antibiotic therapy with anaerobic coverage, anticoagulant drugs and supportive care in case of sepsis. Surgical procedures can be required, including drainage of the abscesses, tissue debridement and jugular vein ligation. Evidence for clinical management is extremely poor in the absence of any adequately sized study with clinical outcomes. In this article, we illustrate two cases of Lemierre syndrome not caused by Fusobacterium necrophorum and provide a clinically oriented discussion on the main issues on epidemiology, pathophysiology and management strategies of this disorder. Finally, we summarize the study protocol of a proposed systematic review and individual patient data meta-analysis of the literature. Our ongoing work aims to investigate the risk of new thromboembolic events, major bleeding or death in patients diagnosed with Lemierre syndrome, and to better elucidate the role of anticoagulant therapy in this setting. This effort represents the starting point for an evidence-based treatment of Lemierre syndrome built on multinational interdisciplinary collaborative studies.

Zusammenfassung

Das Lemierre-Syndrom betrifft normalerweise gesunde Jugendliche oder junge Erwachsene und tritt mit einer Gesamttodesrate von 1 bis 10 Fällen pro Million Personenjahre mit einer geschätzten Sterblichkeitsrate von 4 bis 9% auf. Diagnostische Kriterien bleiben umstritten und umfassen akute Kopf-Hals-Bakterieninfektionen (häufig Tonsillitis durch Anaerobier mit hohem Sepsis-und Gefäßinvasionspotenzial, insbesondere Fusobacterium necrophorum), kompliziert durch lokale Venenthrombose, die gewöhnlich die Vena jugularis interna involviert, und systemische septische Embolie. Die medizinische Behandlung basiert auf einer Antibiotikatherapie mit anaerober Abdeckung, Antikoagulanzien, und unterstützender Behandlung bei Sepsis. Chirurgische Maßnahmen können erforderlich sein, einschließlich der Drainage der Abszesse, Gewebedebridement und Jugularvenenligatur. Die Evidenz für das klinische Management ist in Ermangelung einer ausreichend bemessenen Studie mit klinischen Ergebnissen äußerst schlecht. In diesem Artikel illustrieren wir zwei Fälle von Lemierre-Syndrom, die nicht durch Fusobacterium necrophorum verursacht wurden und bieten eine klinisch orientierte Diskussion über die Hauptprobleme der Epidemiologie, Pathophysiologie und Managementstrategien dieser Erkrankung. Abschließend fassen wir das Studienprotokoll einer vorgeschlagenen systematischen Übersichtsarbeit und einer individuellen Patientendaten-Metaanalyse der Literatur zusammen. Unsere laufende Arbeit zielt darauf ab, das Risiko neuer thromboembolischer Ereignisse, schwerer Blutungen oder Todesfälle bei Patienten mit Lemierre-Syndrom zu untersuchen und die Rolle der Antikoagulanzien-Therapie in diesem Zusammenhang besser zu klären. Diese Bemühungen bilden den Ausgangspunkt für eine evidenzbasierte Behandlung des Lemierre-Syndroms, welche auf multinationalen interdisziplinären kollaborativen Studien aufbaut.

Authors' Contributions

Clara Sacco, Federica Zane, Serena Granziera, Marcello Di Nisio and Alessandro Pecci were responsible for the design of the study, collection of data, writing of the manuscript and gave final approval. Karin Holm and Petros Karkos were responsible for the writing of the manuscript, critical revision of the manuscript and gave final approval. Elena Turpini and Adele Valentini were responsible for collection of data, critical revision of the manuscript and gave final approval. Dina Creemers-Schild, Michael-André Hotz, Christian Righini, Peter Verhamme and Stavros Konstantinides critically revised the manuscript and gave final approval. Stefano Barco was responsible for the concept and design of the study, collection of data, quality assessment and data analysis, writing of the manuscript and gave final approval.


Supplementary Material

 
  • References

  • 1 Lemierre A. On certain septicaemias due to anaerobic organisms. Lancet 1936; 1: 701-703
  • 2 Shannon GW, Ellis CV, Stepp WP. Oropharyngeal bacteroides melaninogenicus infection with septicemia: Lemierre's syndrome. J Fam Pract 1983; 16 (01) 159-160 , 163, 166
  • 3 Karkos PD, Asrani S, Karkos CD. , et al. Lemierre's syndrome: a systematic review. Laryngoscope 2009; 119 (08) 1552-1559
  • 4 Syed MI, Baring D, Murray C. In reference to Lemierre's syndrome: a systematic review. Laryngoscope 2010; 120 (01) 215-216 , author reply 216
  • 5 Riordan T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome. Clin Microbiol Rev 2007; 20 (04) 622-659
  • 6 Holm K, Svensson PJ, Rasmussen M. Invasive Fusobacterium necrophorum infections and Lemièrre's syndrome: the role of thrombophilia and EBV. Eur J Clin Microbiol Infect Dis 2015; 34 (11) 2199-2207
  • 7 Wani P, Antony N, Wardi M, Rodriguez-Castro CE, Teleb M. The forgotten one: Lemierre's syndrome due to Gram-negative rods Prevotella bacteremia. Am J Case Rep 2016; 17: 18-22
  • 8 Huits RM, van Assen S, Wildeboer-Veloo AC, Verschuuren EA, Koeter GH. Prevotella bivia necrobacillosis following infectious mononucleosis. J Infect 2006; 53 (02) e59-e63
  • 9 Chuncharunee A, Khawcharoenporn T. Lemierre's syndrome caused by Klebsiella pneumoniae in a diabetic patient: a case report and review of the literature. Hawaii J Med Public Health 2015; 74 (08) 260-266
  • 10 Garbati MA, Ahsan AM, Hakawi AM. Lemierre's syndrome due to Klebsiella pneumoniae in a 63-year-old man with diabetes: a case report. J Med Case Reports 2012; 6: 97
  • 11 Lee WS, Wang FD, Shieh YH, Teng SO, Ou TY. Lemierre syndrome complicating multiple brain abscesses caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae cured by fosfomycin and meropenem combination therapy. J Microbiol Immunol Infect 2012; 45 (01) 72-74
  • 12 Tsai YJ, Lin YC, Harnnd DJ, Chiang RP, Wu HM. A Lemierre syndrome variant caused by Klebsiella pneumoniae. J Formos Med Assoc 2012; 111 (07) 403-405
  • 13 Osman M, Hasan S, Bachuwa G. Oesophageal cancer presenting as Lemierre's syndrome caused by Streptococcus anginosus . BMJ Case Rep 2017; 2017: bcr-2017-bcr-219661
  • 14 Alberio L, Lämmle B. Images in clinical medicine. Capnocytophaga canimorsus sepsis. N Engl J Med 1998; 339 (25) 1827
  • 15 Kleinjan A, Di Nisio M, Beyer-Westendorf J. , et al. Safety and feasibility of a diagnostic algorithm combining clinical probability, D-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study. Ann Intern Med 2014; 160 (07) 451-457
  • 16 Pijl JP, Glaudemans AWJM, Slart RHJA, Kwee TC. FDG-PET/CT as a new method for diagnosis and whole-body evaluation of Lemierre syndrome. Clin Nucl Med 2017; 42 (08) e377-e380
  • 17 Aliyu SH, Yong PF, Newport MJ. , et al. Molecular diagnosis of Fusobacterium necrophorum infection (Lemierre's syndrome). Eur J Clin Microbiol Infect Dis 2005; 24 (03) 226-229
  • 18 Weesner CL, Cisek JE. Lemierre syndrome: the forgotten disease. Ann Emerg Med 1993; 22 (02) 256-258
  • 19 Hagelskjaer Kristensen L, Prag J. Lemierre's syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey. Eur J Clin Microbiol Infect Dis 2008; 27 (09) 779-789
  • 20 Hagelskjaer LH, Prag J, Malczynski J, Kristensen JH. Incidence and clinical epidemiology of necrobacillosis, including Lemierre's syndrome, in Denmark 1990-1995. Eur J Clin Microbiol Infect Dis 1998; 17 (08) 561-565
  • 21 Jones JW, Riordan T, Morgan MS. Investigation of postanginal sepsis and Lemierre's syndrome in the South West Peninsula. Commun Dis Public Health 2001; 4 (04) 278-281
  • 22 Bank S, Jensen A, Nielsen HM, Kristensen LH, Voldstedlund M, Prag J. Fusobacterium necrophorum findings in Denmark from 2010 to 2014 using data from the Danish microbiology database. APMIS 2016; 124 (12) 1087-1092
  • 23 Brazier JS, Hall V, Yusuf E, Duerden BI. Fusobacterium necrophorum infections in England and Wales 1990-2000. J Med Microbiol 2002; 51 (03) 269-272
  • 24 Leugers CM, Clover R. Lemierre syndrome: postanginal sepsis. J Am Board Fam Pract 1995; 8 (05) 384-391
  • 25 Armstrong AW, Spooner K, Sanders JW. Lemierre's syndrome. Curr Infect Dis Rep 2000; 2 (02) 168-173
  • 26 Chirinos JA, Lichtstein DM, Garcia J, Tamariz LJ. The evolution of Lemierre syndrome: report of 2 cases and review of the literature. Medicine (Baltimore) 2002; 81 (06) 458-465
  • 27 Schmidt M, Horvath-Puho E, Thomsen RW, Smeeth L, Sørensen HT. Acute infections and venous thromboembolism. J Intern Med 2012; 271 (06) 608-618
  • 28 Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006; 367 (9516): 1075-1079
  • 29 Holm K, Frick IM, Björck L, Rasmussen M. Activation of the contact system at the surface of Fusobacterium necrophorum represents a possible virulence mechanism in Lemièrre's syndrome. Infect Immun 2011; 79 (08) 3284-3290
  • 30 Holm K, Rasmussen M. Binding and activation of plasminogen at the surface of Fusobacterium necrophorum. Microb Pathog 2013; 59-60: 29-32
  • 31 Kumar A, Menon S, Nagaraja TG, Narayanan S. Identification of an outer membrane protein of Fusobacterium necrophorum subsp. necrophorum that binds with high affinity to bovine endothelial cells. Vet Microbiol 2015; 176 (1-2): 196-201
  • 32 Liesenborghs L, Verhamme P, Vanassche T. Staphylococcus aureus, master manipulator of the human hemostatic system. J Thromb Haemost 2018; 16 (03) 441-454
  • 33 Peetermans M, Vanassche T, Liesenborghs L, Lijnen RH, Verhamme P. Bacterial pathogens activate plasminogen to breach tissue barriers and escape from innate immunity. Crit Rev Microbiol 2016; 42 (06) 866-882
  • 34 Holm K, Bank S, Nielsen H, Kristensen LH, Prag J, Jensen A. The role of Fusobacterium necrophorum in pharyngotonsillitis - a review. Anaerobe 2016; 42: 89-97
  • 35 Rusan M, Klug TE, Ovesen T. An overview of the microbiology of acute ear, nose and throat infections requiring hospitalisation. Eur J Clin Microbiol Infect Dis 2009; 28 (03) 243-251
  • 36 Trotter C, Borrow R, Andrews N, Miller E. Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era. Vaccine 2003; 21 (11-12): 1094-1098
  • 37 Friberg N, Carlson P, Kentala E. , et al. Factor H binding as a complement evasion mechanism for an anaerobic pathogen, Fusobacterium necrophorum. J Immunol 2008; 181 (12) 8624-8632
  • 38 Holm K, Collin M, Hagelskjær-Kristensen L, Jensen A, Rasmussen M. Three variants of the leukotoxin gene in human isolates of Fusobacterium necrophorum subspecies funduliforme. Anaerobe 2017; 45: 129-132
  • 39 Tadepalli S, Stewart GC, Nagaraja TG, Narayanan SK. Human Fusobacterium necrophorum strains have a leukotoxin gene and exhibit leukotoxic activity. J Med Microbiol 2008; 57 (Pt 2): 225-231
  • 40 Narayanan SK, Nagaraja TG, Chengappa MM, Stewart GC. Leukotoxins of gram-negative bacteria. Vet Microbiol 2002; 84 (04) 337-356
  • 41 Hedin K, Bieber L, Lindh M, Sundqvist M. The aetiology of pharyngotonsillitis in adolescents and adults - Fusobacterium necrophorum is commonly found. Clin Microbiol Infect 2015; 21 (03) 263.e1-263.e7
  • 42 Bondy P, Grant T. Lemierre's syndrome: what are the roles for anticoagulation and long-term antibiotic therapy?. Ann Otol Rhinol Laryngol 2008; 117 (09) 679-683
  • 43 Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369 (09) 840-851
  • 44 Levy MM, Dellinger RP, Townsend SR. , et al; Surviving Sepsis Campaign. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010; 38 (02) 367-374
  • 45 Ferrer R, Artigas A, Levy MM. , et al; Edusepsis Study Group. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008; 299 (19) 2294-2303
  • 46 Seymour CW, Gesten F, Prescott HC. , et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 2017; 376 (23) 2235-2244
  • 47 Cupit-Link MC, Nageswara Rao A, Warad DM, Rodriguez V. Lemierre syndrome: a retrospective study of the role of anticoagulation and thrombosis outcomes. Acta Haematol 2017; 137 (02) 59-65
  • 48 Vanassche T, Peetermans WE, Herregods MC, Herijgers P, Verhamme P. Anti-thrombotic therapy in infective endocarditis. Expert Rev Cardiovasc Ther 2011; 9 (09) 1203-1219
  • 49 Halton JML, Picard AC, Harper R. , et al. Pharmacokinetics, pharmacodynamics, safety and tolerability of dabigatran etexilate oral liquid formulation in infants with venous thromboembolism. Thromb Haemost 2017; 117 (11) 2168-2175
  • 50 Young G, Yee DL, O'Brien SH, Khanna R, Barbour A, Nugent DJ. FondaKIDS: a prospective pharmacokinetic and safety study of fondaparinux in children between 1 and 18 years of age. Pediatr Blood Cancer 2011; 57 (06) 1049-1054
  • 51 Willmann S, Becker C, Burghaus R. , et al. Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban. Clin Pharmacokinet 2014; 53 (01) 89-102
  • 52 Malec L, Young G. Treatment of venous thromboembolism in pediatric patients. Front Pediatr 2017; 5: 26
  • 53 Kearon C, Akl EA, Ornelas J. , et al. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149 (02) 315-352
  • 54 Redford MR, Ellis R, Rees CJ. Fusobacterium necrophorum infection associated with portal vein thrombosis. J Med Microbiol 2005; 54 (Pt 10): 993-995
  • 55 Schulman S, Kearon C. ; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3 (04) 692-694
  • 56 Jackson D, Daly J, Saltman DC. Aggregating case reports: a way for the future of evidence-based health care?. Clin Case Rep 2014; 2 (02) 23-24
  • 57 Vazquez FJ, Paulin P, Rodriguez P, Lubertino M, Gándara E. The outcome of pulmonary vein thrombosis in non-surgical patients. A systematic review and case report. Thromb Haemost 2015; 113 (05) 1151-1154
  • 58 Khalil N, Nicotra A, Rakowicz W. Treatment for meralgia paraesthetica. Cochrane Database Syst Rev 2012; 12: CD004159
  • 59 Buonfrate D, Requena-Mendez A, Angheben A. , et al. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis 2013; 13: 78
  • 60 Cardona Zorrilla AF, Reveiz Herault L, Casasbuenas A, Aponte DM, Ramos PL. Systematic review of case reports concerning adults suffering from neutropenic enterocolitis. Clin Transl Oncol 2006; 8 (01) 31-38
  • 61 George JN, Raskob GE, Shah SR. , et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 1998; 129 (11) 886-890
  • 62 Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, Suarez-Almazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus 2016; 25 (14) 1520-1531
  • 63 Stewart LA, Clarke M, Rovers M. , et al; PRISMA-IPD Development Group. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement. JAMA 2015; 313 (16) 1657-1665